Developments in treatments for rare genetic obesities

Semaglutide and beyond: An update on pharmacotherapy for obesity

Standardising care in the identification and management of patients with post bariatric surgery hypoglycaemia

Stratification of obesity phenotypes to optimise future therapy (IMI SOPHIA)

The future of anti obesity medication

Obesity Services – The Future

Weight loss maintenance through a multidisciplinary Healthy Weight Clinic in Australia.

Liraglutide 3.0mg within a NHS Tier-3/4 weight management service results in similar weight loss compared to regulatory trials – The LIPOSAX first UK real-world evidence study.

Is time restricted eating superior to continuous dietary restraint for weight management?

Cutting Carbs For Weight Management

Live Debate

COVID, Obesity & Diabetes Update

Development of severe gastroparesis and gastric food bezoar following administration of glucagon-like peptide 1-receptor agonist (GLP1-RA) therapy.

Resistant Hypocalcemia in a patient after Roux-en-Y gastric bypass

Gender Differences in Cardiometabolic Abnormalities across Different BMI Categories

Vitamin D Receptor (VDR) Polymorphisms & Metabolic Health Status in a Maltese Cohort

Energy expenditure trends in patients following roux-en-y gastric bypass surgery

Contribution of BMI to ethnic disparities in outcomes following hospitalisation for COVID-19

GLYCAEMIC VARIABILITY ASSESSED BY CONTINUOUS GLUCOSE MONITORING AFTER ROUX-EN-Y GASTRIC BYPASS VS. SLEEVE GASTRECTOMY

Sarcopaenic obesity – how to diagnose and impact on treatment

New developments in appetite research

Weight stigma; implications for the patient-practitioner relationship